SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) ...
A new model improves prediction of spontaneous stone passage using ultrasound and CT. Learn how it can guide conservative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback